Yellox (bromfenac)
- Region
- 🇪🇺 EU
- Active substance
- bromfenac
- Company
- Bausch + Lomb Ireland Limited
- Status
- Authorised
- Therapeutic area
- Pain, Postoperative; Ophthalmologic Surgical Procedures
- CHMP opinion
- Thu 17 Mar 2011
- EU approval
- Wed 18 May 2011
- Application
- EMEA/H/C/001198
- ATC
- S01BC11
- Official record
- www.ema.europa.eu
Indication
Treatment of postoperative ocular inflammation following cataract extraction in adults.
Regulatory milestones
No milestones recorded in the last year.
Follow Yellox
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.